Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Miller

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Health Affairs (Project Hope)|June 10, 2010
Analysis & commentary. Health reform: only a cease-fire in a political hundred years' warThomas P Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
The limits of limited stage lymphomaThomas P Miller
Current Opinion in Oncology|July 14, 2009
Localized large cell lymphoma: is there any need for radiation therapy?Daniel O Persky, Thomas P Miller
The Journal of Allergy and Clinical Immunology|February 8, 2005
Lack of cost-effectiveness of omalizumabThomas P Miller, Mathew J Reeves
Current Hematology Reports|December 30, 2003
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?Sean T Hehn, Thomas P Miller
Health Affairs (Project Hope)|September 10, 2009
How can we make more progress in measuring physicians' performance to improve the value of care?Thomas P Miller, Troyen A Brennan, Arnold Milstein
Seminars in Hematology|October 10, 2006
Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited diseaseThomas P Miller, Catherine M Spier, Lisa Rimsza
Clinical Lymphoma|January 13, 2004
Mood alterations in patients treated with chlorambucilSean T Hehn, Robert T Dorr, Thomas P Miller
Hematology. American Society of Hematology. Education Program|November 25, 2004
Diffuse aggressive lymphomaRichard I Fisher, Thomas P Miller, Owen A O'Connor
The Journal of Allergy and Clinical Immunology|June 24, 2008
An exploration of factors underlying asthma care and morbidity: a factor analysis of clinical variablesThomas P Miller, Frederick L Oswald, Mathew J Reeves
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Health Affairs (Project Hope)|June 10, 2010
Analysis & commentary. Health reform: only a cease-fire in a political hundred years' warThomas P Miller
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
The limits of limited stage lymphomaThomas P Miller
Current Opinion in Oncology|July 14, 2009
Localized large cell lymphoma: is there any need for radiation therapy?Daniel O Persky, Thomas P Miller
The Journal of Allergy and Clinical Immunology|February 8, 2005
Lack of cost-effectiveness of omalizumabThomas P Miller, Mathew J Reeves
Current Hematology Reports|December 30, 2003
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?Sean T Hehn, Thomas P Miller
Health Affairs (Project Hope)|September 10, 2009
How can we make more progress in measuring physicians' performance to improve the value of care?Thomas P Miller, Troyen A Brennan, Arnold Milstein
Seminars in Hematology|October 10, 2006
Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited diseaseThomas P Miller, Catherine M Spier, Lisa Rimsza
Clinical Lymphoma|January 13, 2004
Mood alterations in patients treated with chlorambucilSean T Hehn, Robert T Dorr, Thomas P Miller
Hematology. American Society of Hematology. Education Program|November 25, 2004
Diffuse aggressive lymphomaRichard I Fisher, Thomas P Miller, Owen A O'Connor
The Journal of Allergy and Clinical Immunology|June 24, 2008
An exploration of factors underlying asthma care and morbidity: a factor analysis of clinical variablesThomas P Miller, Frederick L Oswald, Mathew J Reeves
Pageof 7